Serina Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2017 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Serina Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2024.
  • Serina Therapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$5.55M, a 2402% decline year-over-year.
  • Serina Therapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$17M, a 445% decline year-over-year.
  • Serina Therapeutics, Inc. annual Operating Income (Loss) for 2024 was -$17M, a 445% decline from 2023.
  • Serina Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$3.13M, a 55.1% increase from 2022.
  • Serina Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$6.98M, a 12.1% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$17M -$13.9M -445% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-24
2023 -$3.13M +$3.85M +55.1% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-24
2022 -$6.98M +$958K +12.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-22
2021 -$7.93M +$2.17M +21.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$10.1M +$2.46M +19.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
2019 -$12.6M -$1.31M -11.7% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 -$11.2M -$4.58M -68.8% Jan 1, 2018 Dec 31, 2018 10-K/A 2020-03-31
2017 -$6.66M Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.